The consensus answer is 72 hours after return of spontaneous circulation (ROSC) in comatose survivors of cardiac arrest, and that clock only starts once the patient has been rewarmed to normothermia if targeted temperature management was used. Both the European Resuscitation Council and the American Heart Association build their prognostication algorithms around that 72-hour post-rewarming mark, and both explicitly warn against earlier formal assessment in patients treated with sedation or cooling. The number is a floor for multimodal testing, not a deadline for withdrawing support.

Where the 72-Hour Figure Comes From and What It Actually Times

Neuroprognostication is the process of estimating neurological outcome in a patient who is comatose after resuscitation. The 72-hour figure is the minimum interval between ROSC and the first formal, multimodal outcome assessment. It is measured from ROSC, not from hospital arrival, not from ICU admission, and not from the moment sedation stops.

The European Resuscitation Council's post-resuscitation care guidelines anchor this at 72 hours or later after ROSC, and specify that in patients treated with targeted temperature management the assessment should occur no sooner than 72 hours after return to normothermia. That distinction matters: a patient cooled for 24 hours and rewarmed over 12 to 16 hours reaches the earliest legitimate assessment window closer to 108 to 112 hours after ROSC. An American Heart Association scientific statement on post-arrest prognostication uses the same 72-hour floor and the same post-rewarming caveat.

The 72-hour mark is not when a decision gets made in isolation. It is when the first reliable data set can be assembled. Confounders that distort examination and electrophysiology — residual sedation, neuromuscular blockade, hypothermia itself, metabolic derangement, and shock — are expected to have cleared by then, so the findings gathered at that point can be trusted enough to feed a multimodal algorithm.

Why Earlier Assessment Fails: Sedation, Paralysis, and Hypothermia Stack the Deck

Anticipate a falsely grim examination if you test before the confounders clear. A patient still carrying propofol from a procedural infusion can be areflexic and unreactive with no brain injury at all. A patient with residual neuromuscular blockade from intubation can look like they have no motor response when they are simply paralyzed.

Hypothermia itself suppresses the exam independently of drugs. Cooling reduces the pupillary light reflex and brainstem responses in patients who later wake up, which is exactly why the guidelines shifted the clock to start after rewarming rather than after cooling began. The temperature effect is dose-dependent on how cold the patient got and how long they stayed there, so a protocol targeting 33°C for 24 hours leaves a deeper and longer confounder footprint than one targeting 36°C.

Time also fixes metabolic confounders that mimic devastating injury. Profound acidosis, severe hypoxemia, hepatic or renal dysfunction, and high-dose vasopressor requirements all blunt neurological responses. By 72 hours most of these are either resolving or have resolved enough that the examination reflects the brain rather than the resuscitation.

The practical failure mode is an early comfort-care conversation driven by a single bad exam. The literature on self-fulfilling prophecy in post-arrest care is extensive enough that both major guidelines explicitly caution against withdrawing life-sustaining treatment on the basis of any single predictor, and especially against doing so within the first 72 hours.

The Full Assessment Clock: Hour Markers Beyond the First 72

The 72-hour floor is the start of the formal assessment window, not the only checkpoint. Different tests have different reliability curves, and the widely used algorithm in the ERC guidelines sequences them.

Timepoint What is assessed Reliability caveat
0–72 hours after ROSC Continuous EEG if available, serial examination, treat seizures, control temperature and glucose Findings are not yet definitive; sedation and cooling confound
72 hours (or 72+ hours after rewarming) Bilateral pupillary light reflex, corneal reflex, motor response to pain Confounded by residual sedation, neuromuscular blockade, organ failure
72+ hours Somatosensory evoked potentials (N20 response), neuron-specific enolase, EEG background and reactivity N20 absence is highly specific but not perfectly sensitive; NSE thresholds vary by assay
72+ hours to days CT or MRI of the brain Imaging changes lag behind injury and evolve over days
Any point Multimodal integration — never a single test A single adverse predictor is insufficient to predict poor outcome

The ERC algorithm treats bilateral absent pupillary reflexes at 72 hours or later as strongly predictive of poor outcome but still requires corroboration. The same logic applies to an absent N20 cortical response on SSEP, which is the most specific single test in the panel but misses a meaningful fraction of patients who still have poor outcomes despite preserved N20.

Neuron-specific enolase is where the clock gets messier. NSE rises after arrest, peaks in the first 24 to 48 hours, and then falls. The threshold that predicts poor outcome depends on the assay — the ERC guidelines historically cited roughly 33 micrograms per liter for a commonly used assay, but the exact cutoff is lab-specific and should be taken from the local laboratory's validated value, not from a textbook. A high NSE drawn too early can reflect hemolysis or a non-neurological source, which is another reason the sample is usually drawn in the 48-to-72-hour window.

The Temperature Dependence: Why Cooled Patients Get a Later Clock

Targeted temperature management does more than shift the assessment window. It changes what the window contains. A patient who received TTM at 33°C for 24 hours and was rewarmed slowly has had their brain at a lower metabolic rate for a day, which prolongs the washout of sedatives with high lipid solubility and blunts the recovery trajectory in the early hours.

The ERC guideline language is specific: in patients treated with TTM, prognostication must be delayed until at least 72 hours after the return to normothermia. If a center targets 36°C instead of 33°C, the practical effect is smaller but the rule doesn't change, because the confounding is sedation and rewarming kinetics rather than the depth of cooling alone.

Consider a worked timeline. A patient arrested at 14:00 on day 0, cooled to 33°C for 24 hours, and rewarmed over 16 hours is normothermic around 06:00 on day 2. The earliest legitimate multimodal assessment is then 06:00 on day 5. If a clinician instead uses day 3 at 14:00 — 72 hours from ROSC — they are 16 hours short of the earliest defensible window. That arithmetic is why the "72 hours after ROSC" shorthand has to be read alongside the rewarming clause rather than instead of it.

Centers that do not use TTM at all have a simpler clock: 72 hours from ROSC, provided sedation has been cleared and confounders addressed. That conditional is doing real work in the guideline, and it's the one clinicians most often skip.

The Multimodal Rule: Why No Single Number Replaces the Panel

No single test, at any hour, is sufficient on its own. The ERC and AHA both frame prognostication as a multimodal process, and the 72-hour figure is the earliest point at which the panel can be assembled usefully, not a threshold that transforms any one test into a decision.

The practical panel includes at least two independent modalities. The clinical examination — pupillary light reflex, corneal reflex, motor response — is the cheapest and most available. SSEP N20 is the most specific electrophysiological test. EEG background and reactivity add information about cortical function and seizure burden. Neuron-specific enolase adds a serum biomarker. CT and MRI add structural data that evolves over the first several days.

Discordant results are common and are precisely why the rule exists. A patient with absent pupillary reflexes but preserved N20, or with a malignant EEG background but a reactive examination, cannot be classified confidently at 72 hours. The correct move in that situation is to continue supportive care and reassess, often at 5 to 7 days, rather than to treat the earliest adverse finding as decisive.

A concrete edge case: a patient with an absent N20 on SSEP at 72 hours but preserved pupillary reflexes and no malignant EEG features. The SSEP result alone would predict poor outcome with high specificity, but the discordance with other modalities means the prediction is not reliable enough to justify withdrawal. The guidelines; language about self-fulfilling prophecy exists for exactly this scenario.

Confounders That Reset the Clock: What Justifies Waiting Longer

The 72-hour figure assumes the confounders have cleared. When they haven't, the clock effectively restarts. Both guidelines name the same short list: residual sedation, neuromuscular blockade, hypothermia, severe metabolic derangement, shock, and organ failure.

Residual sedation is the most common reason to delay. A patient with hepatic or renal dysfunction clears midazolam and propofol far more slowly than a patient with normal organ function, and a fentanyl infusion in a patient with renal failure can accumulate. If the sedation cannot be confidently cleared by 72 hours, the examination and EEG at 72 hours are not interpretable, and the assessment should be deferred.

Severe shock and multiorgan failure are the second common reason. A patient on high-dose vasopressors with acute kidney injury and liver dysfunction has a metabolic milieu that blunts neurological responses independent of the brain injury. The guidelines treat this as a confounder that warrants deferring prognostication rather than a reason to accept an adverse exam at face value.

Seizures and status epilepticus deserve their own mention. Both guidelines recommend treating electrographic seizures aggressively and reassessing, because a patient with uncontrolled seizures at 72 hours has an uninterpretable examination and EEG. The assessment is delayed until seizure control has been achieved and the postictal period has passed.

What the 72-Hour Rule Does Not Mean: Common Misreadings

Three misreadings of the rule are common enough to name. The first is that 72 hours is when withdrawal of life-sustaining treatment should occur. It is not. The guidelines are explicit that no single predictor and no single timepoint justifies withdrawal, and that the decision requires a multimodal assessment with confounders addressed.

The second misreading is that the clock starts at ICU admission or at the start of cooling. It starts at ROSC. That distinction matters for any patient whose resuscitation was prolonged, whose transport was delayed, or who was cooled at a referring facility before transfer.

The third misreading is that 72 hours is sufficient for every patient. It is the earliest defensible window, not a universal one. Patients with persistent confounders, discordant multimodal results, or ongoing seizures need longer, and the guidelines support reassessment at 5 to 7 days and beyond in those cases.

A fourth, subtler misreading: that 72 hours of observation alone is equivalent to 72 hours of multimodal assessment. It isn't. The window only counts if the data are actually gathered — serial examinations documented, EEG recorded, SSEP performed, NSE drawn at the right time. A patient observed for 72 hours without those tests has not been prognosticated at 72 hours; they have simply survived 72 hours.

How Centers Operationalize the Window: Real Protocol Differences

Protocols differ in ways that change the effective assessment time. A center that targets 33°C for 24 hours and rewarns at 0.25°C per hour takes about 12 to 16 hours to reach normothermia, so the earliest assessment lands around 108 to 112 hours post-ROSC. A center targeting 36°C with a faster rewarm may reach the window closer to 96 hours.

Some centers stop sedation for the 72-hour examination and some do not, and this is where the biggest practice gap sits. A patient who cannot be examined off sedation at 72 hours needs the assessment deferred, and protocols that automatically run the exam regardless of sedation status are running an uninterpretable test.

The NSE timing is another operational difference. The ERC algorithm draws NSE in the 48-to-72-hour window, but the exact threshold is assay-dependent, and a center using a different assay must use its own validated cutoff. A clinician applying a textbook cutoff to a different assay can get a false-positive or false-negative classification.

A worked example of the whole sequence: ROSC at 00:00 on day 1, TTM at 33°C for 24 hours, rewarmed to normothermia by 18:00 on day 2, sedation held from 20:00 on day 2, examination and EEG at 20:00 on day 5 (72 hours post-rewarming), SSEP and NSE drawn at the same time, CT at 24 to 48 hours after that if indicated, and a multidisciplinary family meeting only after the multimodal data are assembled. That is roughly 116 hours from ROSC to the earliest legitimate decision-support conversation.

FAQ

Does the 72-hour clock start at ROSC or at hospital arrival?

It starts at ROSC. The ERC and AHA guidelines both anchor the interval to the moment circulation was restored, not to ICU admission. A patient with a 40-minute transport from a referring hospital has 40 fewer hours of observation left when they arrive, which is why the transfer time has to be documented in the chart.

Does targeted temperature management change the 72-hour number?

Yes. In patients treated with TTM, the ERC guideline specifies prognostication no sooner than 72 hours after return to normothermia, not 72 hours after ROSC. A 24-hour cooling protocol plus a 12-to-16-hour rewarm pushes the earliest defensible assessment to roughly 108 to 112 hours post-ROSC.

Can a patient be prognosticated earlier if they were never sedated or cooled?

The guideline floor still applies in most protocols. Patients who were never cooled and never sedated have fewer confounders, but the 72-hour interval remains the standard because the natural history of post-arrest brain injury is still evolving. Earlier assessment is not supported by the major guidelines even in that subgroup.

What if the SSEP and the clinical examination disagree at 72 hours?

Continue supportive care and reassess. Discordant multimodal results are exactly the scenario the guidelines warn about, and the correct response is to defer the decision rather than to privilege one test. Reassessment at 5 to 7 days, with repeat examination, EEG, and imaging, is the standard approach.

Is the NSE threshold the same at every hospital?

No. The cutoff is assay-dependent, and the commonly cited figure of roughly 33 micrograms per liter applies to specific assays. Each laboratory should provide its own validated threshold, and a clinician applying a textbook number to a different assay can misclassify the patient.

How long does the full assessment actually take in practice?

Plan for 96 to 120 hours from ROSC in a cooled patient, depending on rewarming speed and how quickly sedation clears. The 72-hour figure is the earliest point at which the first multimodal data set can be gathered, not the point at which a family meeting should be scheduled.

Can a patient with an adverse exam at 72 hours still recover?

Recovery despite an adverse 72-hour examination is uncommon but documented, particularly when the adverse finding is a single modality and the others are discordant or preserved. That possibility is the reason the guidelines require multimodal assessment and prohibit withdrawal on a single predictor.

Does the rule apply to in-hospital cardiac arrest the same way?

The guidelines do not carve out a separate interval for in-hospital arrest, and the same 72-hour post-ROSC (or post-rewarming) floor applies. In-hospital arrests often carry more comorbidity and more residual sedation, which makes the confounder-clearing condition harder to meet and pushes the effective assessment later.

This article is general educational information about post-arrest prognostication and is not a diagnosis, treatment plan, or substitute for clinical judgment. Decisions about prognostication and withdrawal of life-sustaining treatment must be made by a qualified local clinical team using the applicable institutional protocol and current resuscitation guidelines, and any patient-specific question should go to that team. In an emergency or crisis, contact local emergency services immediately.